At UCLA, Dr. David Nathanson is designing new therapies that tackle glioblastoma’s unique tumor biology, aiming to overcome long-standing treatment challenges.
The analysis of nearly 94,000 participants in UCLA’s ATLAS Biobank highlights the value of genetic diversity in developing precision health strategies.
In an alternate world, UCLA professor Anne Andrews might be a CIA agent. But in this one, she’s a scientist breaking new ground measuring chemicals in the brain and body.
After years of hospital stays and fear, families are watching their kids thrive. Today, the gene therapy they received earned accelerated approval from the FDA.
By equipping T cells with two proteins derived from fungi, the researchers enabled the immune cells to import cellobiose and convert it into usable glucose inside the cell.